Blog - Page 1089 of 5706

FridayJan 21, 2022 11:40 am

QualityStocksNewsBreaks – Nowigence Inc.’s Pluaris(TM) Platform Enabling Users as AI Gains Steam

Nowigence, a fast-growing software-as-a-service (“SaaS”) company that has developed an innovative, ready-to-use artificial intelligence (“AI”) platform called Pluaris(TM), is establishing a stronghold in the burgeoning AI space. Accelerated by the global pandemic, the adoption of AI is gaining steam, with 2022 projected to be a year when AI becomes a mainstream technology. “Nowigence’s Pluaris is a cloud-based app created for just this time and place, enabling users to read more in less time. The innovative platform allows individuals, teams and enterprises to quickly evaluate and analyze knowledge from massive amounts of public and private textual data,” reads a recent article.…

FridayJan 21, 2022 10:55 am

QualityStocksNewsBreaks – DeFi Technologies Inc. (NEO: DEFI) (GR: RMJ.F) (OTC: DEFTF) Featured in Broadcast Discussing Successful Close of SEBA Bank Funding

DeFi Technologies Inc. (NEO: DEFI) (GR: RMJ.F) (OTC: DEFTF), a digital asset investment firm bridging the gap between traditional capital markets and decentralized finance, is featured in a NetworkNewsAudio (“NNA”) release. The audio press release covers the recent closing of a CHF110 million Series C funding round into SEBA Bank; the bank is a fully integrated, FINMA-licensed digital assets banking platform. According to the release, the funding was co-led by DeFi Technologies, which made an investment of CHF25 million. As a result of that investment, DeFi Technologies will be allotted a seat on SEBA Bank's board of directors. Other funding…

FridayJan 21, 2022 10:37 am

Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0) Corporate Update Points to Profitability in 2022 and Beyond

In 2021, Delic’s investments and acquisitions allowed for an annualized revenue run-rate of over $9MM Going into the new year, the company looks forward to opening additional ketamine infusion treatment clinics, growing them by 15 within the next 18 months Delic’s growth has been attributed to the strong demand for alternatives to current treatments for mental health conditions Its management is confident that the foundations laid down so far position Delic for growth and profitability in 2022 and beyond 2021 was an excellent year for Delic Holdings (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0), as indicated in the company’s recent update…

FridayJan 21, 2022 10:29 am

Eat Well Investment Group Inc. (CSE: EWG) (OTC: EWGFF) Engages Leading Digital Merchandising Agency to Tap into Ongoing Growth in Snack Food Market by Driving Amazon Sales of Portfolio Products

Eat Well Group has engaged Avenue7Media, a leading digital merchandising agency, to develop the online snacking platform for Eat Well Group portfolio products The platform, scheduled for delivery in Spring 2022, will help Eat Well grow its portfolio investment, brands, and consumer products, through Amazon.com The snacking culture has grown over the last few years, and e-commerce has offered a convenient avenue to shop for snacks Eat Well Group has also engaged several other service providers as it looks to expand its North American and European digital and market awareness campaigns Over the recent years, a growing number of people…

FridayJan 21, 2022 10:23 am

PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) Builds on 2021 Growth with Plans for 86 Plant-based Store Outlets, Ongoing Educational Efforts in Coming Year

Plant-based lifestyle brand builder PlantX Life Inc. offers more than 5,000 plant-based products through meal and indoor plant deliveries, and the company is working through research and development to introduce new product categories in the coming year PlantX is also adding to its physical XMarket store locations, advancing from initial British Columbia and California outlets to new locations in Ontario (Toronto and Ottawa), with further XMarket brand transition under way at stores in the Chicago area of Illinois The company is also preparing to open a new store and e-commerce presence in Tel Aviv, Israel this month as part of…

FridayJan 21, 2022 9:36 am

FingerMotion Inc. (NASDAQ: FNGR) Q3 Financial Report Notes Record Profit Growth, Ongoing Efforts to Build SMS, Big Data Services

U.S.-based communications technology brand FingerMotion is building its profits as it focuses on services for China’s world-leading, mobile-connected population FingerMotion recently reported its financial statement for the Q3 quarter ending Nov. 30, noting gross profits at a record $967,075 The profits report was 56 percent higher than the same period during the previous year, driven primarily by the company’s Telecommunications Products and Services business FingerMotion’s Telecommunications Products and Services revenues grew 580 percent YOY despite a slowing trend for SMS services as the company shifted resources to the company’s collaboration with China Mobile in the country’s Fujian province for 5G-related…

ThursdayJan 20, 2022 1:24 pm

Nowigence Inc. (NOWG) Offers PKM Solution with Proprietary Pluaris Platform

Personal knowledge management involves creating systems, adding context and making information easy to surface when needed The customizable, user-friendly Pluaris platform assists users with reading and analyzing textual data and so much more Nowigence is focused on simplifying the challenges of learning The idea of personal knowledge management (“PKM”) systems is gaining traction, with a growing number of individuals and companies recognizing the importance of managing information more efficiently for more successful outcomes. Seeing an opportunity to provide critical support in this quest for knowledge management, Nowigence Inc. (NOWG) has created Pluaris(TM), a cloud-based app that automates reading and analysis of textual…

ThursdayJan 20, 2022 1:19 pm

Nemaura Medical Inc. (NASDAQ: NMRD) Firmly Positioned in Growing Diabetes Tech Market With Recent CGM Shipment to UK Licensee

Diabetes tech market expanded in 2021 due to new users, growing demand for CGM devices, coverage of CGM devices by CMS Diabetes is a growing problem in the US. According to CDC, roughly 1 in 10 Americans have diabetes, and 1 in 3 have pre-diabetes NMRD currently commercializing the sugarBEAT(R) non-invasive and flexible continuous glucose monitor Company recently completed initial shipment to UK licensee While most medical technology businesses faced COVID-19-related restrictions (https://ibn.fm/NJbOa), Nemaura Medical (NASDAQ: NMRD), a medical technology company that develops affordable diagnostic and digital tools for diabetes management, is favorably positioned in the rapidly growing diabetes tech…

ThursdayJan 20, 2022 1:03 pm

QualityStocksNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) CEO Featured in EDGE Podcast Interview

Lexaria Bioscience (NASDAQ: LEXX) CEO and chair Chris Bunka is the guest on a recent episode of the EDGE podcast. Hosted by entrepreneur and angel investor Brandon C. White, the EDGE is a podcast series focused on providing a playbook for business owners that takes a look at the inner game of building a successful business and giving listeners the edge to become smarter, healthier and richer. Lexaria Bioscience is a global innovator in drug-delivery platforms. During the interview, Bunka shared his background and the journey that led him to Lexaria. He also talked about Lexaria’s business model and the…

ThursdayJan 20, 2022 12:59 pm

Lexaria Bioscience Corp. (NASDAQ: LEXX) Marks Great Start to its 2022 R&D Programs Following Independent Review Board Approval

Lexaria received independent review board approval for its HYPER-H21-4 human clinical study for hypertension treatment The stage is also set for other R&D programs for the 2022 calendar year, including HOR-A22-1, DEM-A22-1, RHEUM-A22-1 and DIAB-A22-1 All of these 2022 R&D programs are fully funded, with Lexaria having raised approximately $15 million over the 2021 calendar year Lexaria believes that these programs will build significant value for its stakeholders and pursue policies for substantial improvements to human health In late 2021, Lexaria Bioscience (NASDAQ: LEXX) announced several new and ongoing R&D programs for its patented DehydraTECH(TM) technology. While making the announcement,…

Site Search

Company Search